HDR Syndrome Accompanying Type 1 Diabetes Mellitus and Hypopituitarism
Clicks: 322
ID: 7939
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
69.7
/100
322 views
226 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #4 of 41 articles by views in case reports in endocrinology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
HDR (Hypoparathyroidism, Deafness, and Renal Dysplasia) syndrome is an autosomal dominant disorder characterized by the triad of hypoparathyroidism, sensorineural deafness, and renal disease. Approximately 65% of patients with HDR syndrome have all three of these features, while others have different combinations of these features. We aimed to present a case with primary hypoparathyroidism, hearing loss, and nondiabetic chronic kidney disease and diagnosed as HDR syndrome while being followed up for type 1 diabetes mellitus and hypopituitarism.
| Reference Key |
mustafa2019hdrcase
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Can, Mustafa;Karakurt, Feridun;Kocabas, Muhammed;Cordan, İlker;Karakose, Melia;Kulaksızoglu, Mustafa;Can, Mustafa;Karakurt, Feridun;Kocabas, Muhammed;Cordan, İlker;Karakose, Melia;Kulaksızoglu, Mustafa; |
| Journal | case reports in endocrinology |
| Year | 2019 |
| DOI |
10.1155/2019/7276947
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.